FDA Approves Vanflyta Regimen for AML Subset 🔗 Access full article via CureTodayThe Food and Drug Administration approved a Vanflyta regimen for patients with FLT-ITD—positive acute myeloid leukemia. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
